158 related articles for article (PubMed ID: 8959518)
41. [Recent topics on important drugs for H. pylori eradication: Amoxicillin (AMPC)].
Hiramatsu K; Nasu M
Nihon Rinsho; 2005 Nov; 63 Suppl 11():367-71. PubMed ID: 16363561
[No Abstract] [Full Text] [Related]
42. Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole.
Ortiz RA; Calafatti SA; Corazzi A; Souza JM; Deguer M; De Souza CA; Marchioretto MA; Bernasconi G; Ferraz JG; Pedrazzoli J
Aliment Pharmacol Ther; 2002 Jun; 16(6):1163-70. PubMed ID: 12030960
[TBL] [Abstract][Full Text] [Related]
43. In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.
Hirschl AM; Apfalter P; Makristathis A; Rotter ML; Wimmer M
Antimicrob Agents Chemother; 2000 Jul; 44(7):1977-9. PubMed ID: 10858365
[TBL] [Abstract][Full Text] [Related]
44. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
[TBL] [Abstract][Full Text] [Related]
45. Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.
Jain P; Jain S; Prasad KN; Jain SK; Vyas SP
Mol Pharm; 2009; 6(2):593-603. PubMed ID: 19718807
[TBL] [Abstract][Full Text] [Related]
46. The bifidogenic growth stimulator inhibits the growth and respiration of Helicobacter pylori.
Nagata K; Inatsu S; Tanaka M; Sato H; Kouya T; Taniguchi M; Fukuda Y
Helicobacter; 2010 Oct; 15(5):422-9. PubMed ID: 21083748
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.
Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC
J Chemother; 1996 Dec; 8(6):425-31. PubMed ID: 8981182
[TBL] [Abstract][Full Text] [Related]
48. Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives.
Yoshida Y; Barrett D; Azami H; Morinaga C; Matsumoto S; Matsumoto Y; Takasugi H
Bioorg Med Chem; 1999 Nov; 7(11):2647-66. PubMed ID: 10632076
[TBL] [Abstract][Full Text] [Related]
49. Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
Lambert JR
Gastroenterology; 1996 Aug; 111(2):521-3. PubMed ID: 8690219
[No Abstract] [Full Text] [Related]
50. In vitro and in vivo effects of the Mongolian drug Amu-ru 7 on Helicobacter pylori growth and viability.
Bai CL; Osaki T; Yonezawa H; Hanawa T; Zaman C; Kurata S; Kamiya S; Tanaka H
Microbiol Immunol; 2010 Sep; 54(9):508-15. PubMed ID: 20840149
[TBL] [Abstract][Full Text] [Related]
51. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
Rajinikanth PS; Balasubramaniam J; Mishra B
Int J Pharm; 2007 Apr; 335(1-2):114-122. PubMed ID: 17141986
[TBL] [Abstract][Full Text] [Related]
52. Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin.
Irie Y; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 1997 Aug; 40(2):235-40. PubMed ID: 9301989
[TBL] [Abstract][Full Text] [Related]
53. Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins.
Dore MP; Graham DY; Sepulveda AR; Realdi G; Osato MS
Antimicrob Agents Chemother; 1999 Jul; 43(7):1803-4. PubMed ID: 10390249
[TBL] [Abstract][Full Text] [Related]
54. Effect of glycine on Helicobacter pylori in vitro.
Minami M; Ando T; Hashikawa SN; Torii K; Hasegawa T; Israel DA; Ina K; Kusugami K; Goto H; Ohta M
Antimicrob Agents Chemother; 2004 Oct; 48(10):3782-8. PubMed ID: 15388434
[TBL] [Abstract][Full Text] [Related]
55. Evolution of amoxicillin resistance of Helicobacter pylori in vitro: characterization of resistance mechanisms.
Qureshi NN; Gallaher B; Schiller NL
Microb Drug Resist; 2014 Dec; 20(6):509-16. PubMed ID: 24901497
[TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.
Rong Q; Xu M; Dong Q; Zhang Y; Li Y; Ye G; Zhao L
BMC Complement Altern Med; 2016 Aug; 16(1):331. PubMed ID: 27576439
[TBL] [Abstract][Full Text] [Related]
57. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
[TBL] [Abstract][Full Text] [Related]
58. Substitutions in penicillin-binding protein 1 in amoxicillin-resistant Helicobacter pylori strains isolated from Korean patients.
Kim BJ; Kim JG
Gut Liver; 2013 Nov; 7(6):655-60. PubMed ID: 24312705
[TBL] [Abstract][Full Text] [Related]
59. Influence of amoxicillin, erythromycin and metronidazole on adherence of Helicobacter pylori.
Brenciaglia MI; Fornara AM; Scaltrito MM; Dubini F
New Microbiol; 1995 Jul; 18(3):283-8. PubMed ID: 7553363
[No Abstract] [Full Text] [Related]
60. Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori.
Co EM; Schiller NL
Antimicrob Agents Chemother; 2006 Dec; 50(12):4174-6. PubMed ID: 17000747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
